{"hands_on_practices": [{"introduction": "The stability of the peptide-MHC (pMHC) complex is a cornerstone of adaptive immunity, directly influencing the magnitude and quality of the T-cell response. This stability is largely determined by the binding affinity of the peptide, which can be understood as the sum of energetic contributions from various interactions within the binding groove. This exercise [@problem_id:2869306] provides a foundational understanding of this concept by asking you to apply a simplified, additive free energy model. By calculating the change in binding free energy ($\\Delta G$) resulting from the loss of a single optimal anchor residue, you will gain a quantitative appreciation for how specific side-chain interactions dictate the overall strength of peptide binding.", "problem": "Consider peptide binding to Major Histocompatibility Complex (MHC) class II, whose peptide-binding groove accommodates a nonameric core with primary anchor positions at pockets commonly denoted as P1, P4, P6, and P9. Assume a simplified thermodynamic model in which the standard binding free energy of a peptide, denoted by $\\Delta G$, can be decomposed into a baseline contribution $\\Delta G_{0}$ that accounts for non-pocket interactions and global entropic costs, plus an additive sum of per-pocket contributions that arise from side-chain complementarity at each anchor pocket. Specifically, suppose that an “optimal” anchor residue in any of the four pockets contributes a favorable free energy increment of $-2$ kcal/mol relative to a nonoptimal residue, and nonoptimal or absent contributions are $0$ in this model. All other terms, including peptide length, register entropy, and non-anchor contact contributions, are identical between the two peptides and are fully captured in $\\Delta G_{0}$.\n\nUsing this additive pocket energy model and starting from the thermodynamic definition of binding free energy as a state function, derive the expression for the difference in standard binding free energies, $\\Delta \\Delta G \\equiv \\Delta G_{\\text{four}} - \\Delta G_{\\text{three}}$, between a peptide with four optimal anchors (one in each of P1, P4, P6, P9) and a peptide with three optimal anchors (optimal in three of these pockets and nonoptimal in the fourth). Compute the numerical value of $\\Delta \\Delta G$ under the stated assumptions. Express your final numerical answer in kcal/mol as an exact value; do not round.", "solution": "The problem is valid as it is scientifically grounded in a standard, albeit simplified, model of molecular recognition in immunology, is well-posed, objective, and contains all necessary information for a unique solution.\n\nThe thermodynamic definition of binding free energy, $\\Delta G$, as a state function implies that its value depends only on the initial and final states of the system (unbound and bound, respectively) and not on the pathway of binding. This principle allows the decomposition of the total free energy change into a sum of independent contributions from different interactions, as specified in the problem statement.\n\nThe model provides an additive decomposition of the standard binding free energy $\\Delta G$ as:\n$$ \\Delta G = \\Delta G_{0} + \\sum_{i \\in \\mathcal{P}} \\Delta g_i $$\nHere, $\\mathcal{P}$ represents the set of four primary anchor pockets, $\\{P1, P4, P6, P9\\}$. The term $\\Delta G_{0}$ is a constant baseline contribution, identical for both peptides under consideration. The term $\\Delta g_i$ represents the free energy contribution from the amino acid side-chain occupying the $i$-th pocket.\n\nThe problem defines the values for these pocket contributions as:\n$$ \\Delta g_i^{\\text{optimal}} = -2 \\text{ kcal/mol} $$\n$$ \\Delta g_i^{\\text{nonoptimal}} = 0 \\text{ kcal/mol} $$\n\nFirst, we formulate the expression for the standard binding free energy of the peptide with four optimal anchors, denoted $\\Delta G_{\\text{four}}$. In this case, each of the four anchor pockets is occupied by an optimal residue.\n$$ \\Delta G_{\\text{four}} = \\Delta G_{0} + \\Delta g_{P1}^{\\text{optimal}} + \\Delta g_{P4}^{\\text{optimal}} + \\Delta g_{P6}^{\\text{optimal}} + \\Delta g_{P9}^{\\text{optimal}} $$\nSubstituting the given value, we have:\n$$ \\Delta G_{\\text{four}} = \\Delta G_{0} + 4 \\times (-2 \\text{ kcal/mol}) $$\n$$ \\Delta G_{\\text{four}} = \\Delta G_{0} - 8 \\text{ kcal/mol} $$\n\nSecond, we formulate the expression for the standard binding free energy of the peptide with three optimal anchors and one nonoptimal anchor, denoted $\\Delta G_{\\text{three}}$. The model assumes all pockets are equivalent in their potential energetic contribution, so the specific pocket that contains the nonoptimal residue is irrelevant. We can write the expression as a sum of three optimal contributions and one nonoptimal contribution.\n$$ \\Delta G_{\\text{three}} = \\Delta G_{0} + 3 \\times (\\Delta g^{\\text{optimal}}) + 1 \\times (\\Delta g^{\\text{nonoptimal}}) $$\nSubstituting the given values:\n$$ \\Delta G_{\\text{three}} = \\Delta G_{0} + 3 \\times (-2 \\text{ kcal/mol}) + 1 \\times (0 \\text{ kcal/mol}) $$\n$$ \\Delta G_{\\text{three}} = \\Delta G_{0} - 6 \\text{ kcal/mol} $$\n\nThe objective is to derive an expression for the difference in standard binding free energies, $\\Delta \\Delta G$, defined as $\\Delta \\Delta G \\equiv \\Delta G_{\\text{four}} - \\Delta G_{\\text{three}}$. We proceed by substituting the expressions derived above:\n$$ \\Delta \\Delta G = (\\Delta G_{0} - 8 \\text{ kcal/mol}) - (\\Delta G_{0} - 6 \\text{ kcal/mol}) $$\nThe constant baseline term $\\Delta G_{0}$ cancels, which is expected as we are calculating a difference between two systems where this contribution is identical.\n$$ \\Delta \\Delta G = \\Delta G_{0} - 8 \\text{ kcal/mol} - \\Delta G_{0} + 6 \\text{ kcal/mol} $$\nThis simplifies to:\n$$ \\Delta \\Delta G = -8 \\text{ kcal/mol} + 6 \\text{ kcal/mol} $$\n$$ \\Delta \\Delta G = -2 \\text{ kcal/mol} $$\nAlternatively, and more formally, the derivation can be shown as the difference between the sum of individual contributions.\n$$ \\Delta \\Delta G = \\left(\\Delta G_{0} + \\sum_{i=1}^{4} \\Delta g_i^{\\text{optimal}}\\right) - \\left(\\Delta G_{0} + \\sum_{j=1}^{3} \\Delta g_j^{\\text{optimal}} + \\Delta g_k^{\\text{nonoptimal}}\\right) $$\n$$ \\Delta \\Delta G = \\left(\\sum_{i=1}^{4} \\Delta g_i^{\\text{optimal}}\\right) - \\left(\\sum_{j=1}^{3} \\Delta g_j^{\\text{optimal}} + \\Delta g_k^{\\text{nonoptimal}}\\right) $$\nSince all optimal contributions are equal, this simplifies to:\n$$ \\Delta \\Delta G = \\Delta g^{\\text{optimal}} - \\Delta g^{\\text{nonoptimal}} $$\nSubstituting the numerical values:\n$$ \\Delta \\Delta G = (-2 \\text{ kcal/mol}) - (0 \\text{ kcal/mol}) = -2 \\text{ kcal/mol} $$\nThis result confirms that the difference in binding energy between the two peptides is precisely the energetic contribution of a single optimal anchor side-chain, which is lost when replaced by a nonoptimal one. The problem asks for the numerical value expressed in kcal/mol.\n\nThe computed value is $-2$.", "answer": "$$\\boxed{-2}$$", "id": "2869306"}, {"introduction": "While thermodynamic affinity ($K_d$) measures the equilibrium strength of the pMHC interaction, the kinetic stability of the complex—how long the peptide remains bound—is often more biologically significant. The peptide dissociation rate constant ($k_{\\text{off}}$) is a key determinant of the peptide repertoire displayed on the cell surface, as it influences susceptibility to editing by molecules like HLA-DM and determines the duration of T-cell receptor engagement. This problem [@problem_id:2869268] delves into the critical distinction between thermodynamic and kinetic stability. You will analyze two peptides with identical affinities but different kinetic profiles to predict their half-lives and relative resistance to HLA-DM, highlighting the paramount importance of kinetics in peptide selection.", "problem": "A peptide editor in the endosomal pathway, Human Leukocyte Antigen-DM (HLA-DM), catalyzes the exchange of peptides bound to Major Histocompatibility Complex class II (MHC II) molecules by stabilizing a peptide-receptive conformation. A well-tested observation is that HLA-DM preferentially removes peptide–MHC II complexes with faster peptide dissociation (larger $k_{\\text{off}}$), while complexes with slower dissociation (smaller $k_{\\text{off}}$) tend to be HLA-DM-resistant. At equilibrium, the dissociation constant is defined by $K_d = k_{\\text{off}}/k_{\\text{on}}$. For a first-order dissociation process $C \\xrightarrow{k_{\\text{off}}} R + P$, where $C$ is the complex and $R,P$ are receptor and peptide, respectively, the fraction of complexes remaining over time follows $f(t)=\\exp(-k_{\\text{off}} t)$.\n\nConsider two peptides, $X$ and $Y$, bound to the same MHC II allele under identical conditions. Their kinetic parameters are:\n- $X$: $k_{\\text{on},X} = 2.0 \\times 10^{5}\\ \\text{M}^{-1}\\text{s}^{-1}$ and $k_{\\text{off},X} = 1.0 \\times 10^{-5}\\ \\text{s}^{-1}$,\n- $Y$: $k_{\\text{on},Y} = 1.0 \\times 10^{6}\\ \\text{M}^{-1}\\text{s}^{-1}$ and $k_{\\text{off},Y} = 5.0 \\times 10^{-5}\\ \\text{s}^{-1}$.\n\nUsing only the fundamental definitions above, and the principle that HLA-DM resistance correlates with smaller $k_{\\text{off}}$ (greater kinetic stability), determine which peptide is more HLA-DM-resistant and compute the half-life $t_{1/2}$ of each peptide–MHC II complex. Express each half-life in minutes and round your answers to four significant figures.\n\nLet $I$ be an indicator defined by $I=1$ if peptide $X$ is more HLA-DM-resistant and $I=0$ if peptide $Y$ is more HLA-DM-resistant. Report your final answer as a single row matrix $(I,\\ t_{1/2,X},\\ t_{1/2,Y})$.", "solution": "The problem requires a determination of the relative HLA-DM resistance of two peptides, denoted $X$ and $Y$, and the calculation of the half-life of their respective complexes with an MHC class II molecule.\n\nThe first task is to determine which peptide is more resistant to HLA-DM. The problem statement provides the fundamental principle: HLA-DM resistance is inversely correlated with the peptide dissociation rate constant, $k_{\\text{off}}$. This means a complex with a lower value of $k_{\\text{off}}$ is more kinetically stable and consequently more resistant to HLA-DM-mediated peptide exchange.\n\nWe are given the following kinetic parameters:\nFor peptide $X$: $k_{\\text{off},X} = 1.0 \\times 10^{-5}\\ \\text{s}^{-1}$.\nFor peptide $Y$: $k_{\\text{off},Y} = 5.0 \\times 10^{-5}\\ \\text{s}^{-1}$.\n\nA direct comparison of these two values shows:\n$$1.0 \\times 10^{-5}\\ \\text{s}^{-1} < 5.0 \\times 10^{-5}\\ \\text{s}^{-1}$$\nTherefore, $k_{\\text{off},X} < k_{\\text{off},Y}$. Based on the stated principle, the peptide–MHC II complex involving peptide $X$ is more kinetically stable and thus more resistant to HLA-DM than the complex with peptide $Y$.\n\nThe problem defines an indicator variable, $I$, such that $I=1$ if peptide $X$ is more HLA-DM-resistant and $I=0$ if peptide $Y$ is more HLA-DM-resistant. From our analysis, we conclude that $I=1$.\n\nThe second task is to compute the half-life, $t_{1/2}$, for each complex. The dissociation is described as a first-order process where the fraction of complexes remaining, $f(t)$, at time $t$ is given by:\n$$f(t) = \\exp(-k_{\\text{off}} t)$$\nThe half-life, $t_{1/2}$, is the time required for the concentration of the complex to decrease to half of its initial value. This corresponds to the time when the fraction remaining is $f(t_{1/2}) = \\frac{1}{2}$. We substitute this condition into the rate equation:\n$$\\frac{1}{2} = \\exp(-k_{\\text{off}} t_{1/2})$$\nTo solve for $t_{1/2}$, we take the natural logarithm of both sides:\n$$\\ln\\left(\\frac{1}{2}\\right) = \\ln\\left(\\exp(-k_{\\text{off}} t_{1/2})\\right)$$\nUsing the logarithmic identity $\\ln\\left(\\frac{1}{a}\\right) = -\\ln(a)$, we simplify the equation:\n$$-\\ln(2) = -k_{\\text{off}} t_{1/2}$$\nThis yields the general expression for the half-life of a first-order reaction:\n$$t_{1/2} = \\frac{\\ln(2)}{k_{\\text{off}}}$$\nWe now use this formula to calculate the half-life for each peptide complex.\n\nFor peptide $X$, with $k_{\\text{off},X} = 1.0 \\times 10^{-5}\\ \\text{s}^{-1}$:\n$$t_{1/2,X} = \\frac{\\ln(2)}{1.0 \\times 10^{-5}\\ \\text{s}^{-1}} \\approx 69314.718\\ \\text{s}$$\nThe result must be expressed in minutes. We convert from seconds to minutes by dividing by $60$:\n$$t_{1/2,X} \\approx \\frac{69314.718}{60}\\ \\text{min} \\approx 1155.245\\ \\text{min}$$\nRounding to four significant figures as required, we obtain:\n$$t_{1/2,X} = 1155\\ \\text{min}$$\n\nFor peptide $Y$, with $k_{\\text{off},Y} = 5.0 \\times 10^{-5}\\ \\text{s}^{-1}$:\n$$t_{1/2,Y} = \\frac{\\ln(2)}{5.0 \\times 10^{-5}\\ \\text{s}^{-1}} \\approx 13862.944\\ \\text{s}$$\nConverting to minutes:\n$$t_{1/2,Y} \\approx \\frac{13862.944}{60}\\ \\text{min} \\approx 231.049\\ \\text{min}$$\nRounding to four significant figures, we obtain:\n$$t_{1/2,Y} = 231.0\\ \\text{min}$$\nThe trailing zero is significant and is retained to meet the precision requirement.\n\nThe final answer is the row matrix $(I, t_{1/2,X}, t_{1/2,Y})$, where the half-life values are the numerical results in minutes.", "answer": "$$\\boxed{\\begin{pmatrix} 1 & 1155 & 231.0 \\end{pmatrix}}$$", "id": "2869268"}, {"introduction": "Inside the cell, MHC class II molecules do not encounter peptides in isolation. Instead, they are immersed in a complex milieu of potential binders within the endosomal compartment, all competing for a limited number of binding grooves. The final array of peptides presented on the cell surface is the result of this intense competition. This final practice problem [@problem_id:2869277] challenges you to model this competitive environment. By deriving and applying an equilibrium competitive binding model, you will calculate the fractional occupancy for competing peptides, providing insight into how a peptide's concentration and its intrinsic affinity ($K_d$) combine to determine its success in the struggle for MHC presentation.", "problem": "In the late endosomal compartment, a single Major Histocompatibility Complex class II (MHC II) heterodimer presents antigenic peptides by binding them in an open-ended groove that accommodates peptides of varying length via a single set of key anchor pockets. Consider a minimal equilibrium model in which there is exactly one ($1$) peptide-binding site per MHC II molecule, and multiple peptide species $i \\in \\{1,2,\\dots,n\\}$ are present and compete for this single site. Each peptide $i$ has a free concentration $[L_i]$ and a dissociation constant $K_{d,i}$ for the reaction $R + L_i \\rightleftharpoons RL_i$, where $R$ is free MHC II and $RL_i$ is MHC II bound to peptide $i$. Assume mass-action kinetics at equilibrium, site conservation, and that peptides are in large molar excess over MHC II so that free peptide concentrations $[L_i]$ are effectively equal to their totals.\n\nStarting from the definition of the dissociation constant and the conservation of binding sites, derive an expression for the equilibrium fraction of total MHC II molecules occupied by peptide $i$, denoted $\\theta_i$, in terms of $[L_i]$ and $K_{d,i}$ for $n$ competitors.\n\nThen, apply your derived expression to the following scientifically plausible parameter set for $n=3$ peptides in an endosomal lumen at equilibrium: $[L_1]=2\\,\\mu\\mathrm{M}$, $K_{d,1}=5\\,\\mu\\mathrm{M}$; $[L_2]=0.5\\,\\mu\\mathrm{M}$, $K_{d,2}=0.05\\,\\mu\\mathrm{M}$; $[L_3]=10\\,\\mu\\mathrm{M}$, $K_{d,3}=20\\,\\mu\\mathrm{M}$. Compute the numerical value of $\\theta_2$ as a unitless decimal. Round your answer to four significant figures.", "solution": "The problem statement has been evaluated and is found to be scientifically grounded, well-posed, and objective. It presents a standard model of competitive binding from biophysical chemistry, applied to a relevant immunological context. All necessary parameters and assumptions are provided, and the problem is free of contradictions or vagueness. Therefore, a solution will be provided.\n\nThe objective is to derive an expression for the fractional occupancy of MHC class II molecules by a specific peptide species $i$, denoted $\\theta_i$, in a system with $n$ competing peptide species. We will then use this expression to calculate a specific numerical value.\n\nThe fractional occupancy $\\theta_i$ is defined as the concentration of MHC II bound to peptide $i$, $[RL_i]$, divided by the total concentration of MHC II molecules, $[R]_{\\text{total}}$.\n$$\n\\theta_i = \\frac{[RL_i]}{[R]_{\\text{total}}}\n$$\nThe total concentration of MHC II, $[R]_{\\text{total}}$, is the sum of the free (unbound) MHC II, $[R]$, and all bound forms. As there are $n$ competing peptide species, we have:\n$$\n[R]_{\\text{total}} = [R] + [RL_1] + [RL_2] + \\dots + [RL_n] = [R] + \\sum_{j=1}^{n} [RL_j]\n$$\nThe interaction between each peptide $L_j$ and the MHC II receptor $R$ is governed at equilibrium by the dissociation constant $K_{d,j}$:\n$$\nK_{d,j} = \\frac{[R][L_j]}{[RL_j]}\n$$\nWe can rearrange this expression to express the concentration of each bound complex, $[RL_j]$, in terms of the free receptor concentration $[R]$, the free ligand concentration $[L_j]$, and the dissociation constant $K_{d,j}$:\n$$\n[RL_j] = \\frac{[R][L_j]}{K_{d,j}}\n$$\nThis applies specifically to peptide $i$ as well:\n$$\n[RL_i] = \\frac{[R][L_i]}{K_{d,i}}\n$$\nNow, substitute the expression for each $[RL_j]$ into the equation for the conservation of total MHC II concentration:\n$$\n[R]_{\\text{total}} = [R] + \\sum_{j=1}^{n} \\frac{[R][L_j]}{K_{d,j}}\n$$\nWe can factor out the common term $[R]$ from the right-hand side:\n$$\n[R]_{\\text{total}} = [R] \\left( 1 + \\sum_{j=1}^{n} \\frac{[L_j]}{K_{d,j}} \\right)\n$$\nWe now have expressions for both the numerator, $[RL_i]$, and the denominator, $[R]_{\\text{total}}$, of $\\theta_i$ that both depend on the unknown free receptor concentration $[R]$. Let us substitute these into the definition of $\\theta_i$:\n$$\n\\theta_i = \\frac{\\frac{[R][L_i]}{K_{d,i}}}{[R] \\left( 1 + \\sum_{j=1}^{n} \\frac{[L_j]}{K_{d,j}} \\right)}\n$$\nThe term $[R]$ appears in both the numerator and the denominator, and since $[R]$ must be non-zero for any binding to occur, we can cancel it. This yields the general expression for the fractional occupancy of peptide $i$:\n$$\n\\theta_i = \\frac{\\frac{[L_i]}{K_{d,i}}}{1 + \\sum_{j=1}^{n} \\frac{[L_j]}{K_{d,j}}}\n$$\nThis is the required general expression.\n\nNext, we apply this formula to the specific case given, with $n=3$ peptides, to compute $\\theta_2$. The parameters are:\n$[L_1]=2\\,\\mu\\mathrm{M}$, $K_{d,1}=5\\,\\mu\\mathrm{M}$\n$[L_2]=0.5\\,\\mu\\mathrm{M}$, $K_{d,2}=0.05\\,\\mu\\mathrm{M}$\n$[L_3]=10\\,\\mu\\mathrm{M}$, $K_{d,3}=20\\,\\mu\\mathrm{M}$\n\nThe expression for $\\theta_2$ is:\n$$\n\\theta_2 = \\frac{\\frac{[L_2]}{K_{d,2}}}{1 + \\frac{[L_1]}{K_{d,1}} + \\frac{[L_2]}{K_{d,2}} + \\frac{[L_3]}{K_{d,3}}}\n$$\nFirst, we compute the dimensionless ratios of concentration to dissociation constant for each peptide. The units of concentration ($\\mu\\mathrm{M}$) cancel.\n$$\n\\frac{[L_1]}{K_{d,1}} = \\frac{2}{5} = 0.4\n$$\n$$\n\\frac{[L_2]}{K_{d,2}} = \\frac{0.5}{0.05} = 10\n$$\n$$\n\\frac{[L_3]}{K_{d,3}} = \\frac{10}{20} = 0.5\n$$\nNow, substitute these values into the expression for $\\theta_2$. The denominator is the sum of these ratios plus $1$:\n$$\n1 + \\sum_{j=1}^{3} \\frac{[L_j]}{K_{d,j}} = 1 + 0.4 + 10 + 0.5 = 11.9\n$$\nThe numerator is the ratio for peptide $2$, which is $10$. Therefore, $\\theta_2$ is:\n$$\n\\theta_2 = \\frac{10}{11.9}\n$$\nPerforming the division gives:\n$$\n\\theta_2 \\approx 0.840336134...\n$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\n\\theta_2 \\approx 0.8403\n$$\nThis result signifies that, under these equilibrium conditions, approximately $84.03\\%$ of all MHC II molecules are occupied by peptide $2$, despite its relatively low concentration, due to its very high affinity (low $K_{d,2}$).", "answer": "$$\\boxed{0.8403}$$", "id": "2869277"}]}